Aura Biosciences, Inc.
AURA
$6.51
$0.213.33%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 22.62M | 23.09M | 23.24M | 22.81M | 21.84M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 113.36M | 108.69M | 102.84M | 96.11M | 93.09M |
| Operating Income | -113.36M | -108.69M | -102.84M | -96.11M | -93.09M |
| Income Before Tax | -106.35M | -101.25M | -94.61M | -86.81M | -82.99M |
| Income Tax Expenses | 116.00K | 133.00K | 85.00K | 113.00K | 226.00K |
| Earnings from Continuing Operations | -106.47 | -101.38 | -94.70 | -86.92 | -83.22 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -106.47M | -101.38M | -94.70M | -86.92M | -83.22M |
| EBIT | -113.36M | -108.69M | -102.84M | -96.11M | -93.09M |
| EBITDA | -112.21M | -107.51M | -101.63M | -94.89M | -91.83M |
| EPS Basic | -1.93 | -1.96 | -1.90 | -1.75 | -1.73 |
| Normalized Basic EPS | -1.20 | -1.22 | -1.19 | -1.09 | -1.08 |
| EPS Diluted | -1.93 | -1.96 | -1.90 | -1.75 | -1.73 |
| Normalized Diluted EPS | -1.20 | -1.22 | -1.19 | -1.09 | -1.08 |
| Average Basic Shares Outstanding | 224.02M | 207.74M | 199.27M | 198.60M | 193.31M |
| Average Diluted Shares Outstanding | 224.02M | 207.74M | 199.27M | 198.60M | 193.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |